论文信息 - A new target for tumor therapy. - 字舞流文

A new target for tumor therapy.

Blocking an oxygen sensor in the endothelial cells that line the blood vessels of tumors may reduce tumor and endothelial hypoxia and repress metastasis.

[1] R. Jain,et al. Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2] Frederik De Smet,et al. Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization , 2009, Cell.

[3] Rakesh K. Jain,et al. Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer , 2008, Nature Reviews Cancer.

[4] Lei Xu,et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.

[5] Rakesh K. Jain,et al. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.